News

CBR Researchers Present at the Clinical Aphasiology Conference 2025

  This past May, four researchers from the BU Center for Brain Recovery attended and presented at the 2025 Clinical Aphasiology Conference in Albuquerque, New Mexico. At the conference, CBR Assistant Scientific Director, Maria Varkanitsa, presented the research “Theory of mind deficits in people with post-stroke aphasia: Prevalence and links to aphasia severity and brain […]

Theory of Mind Deficits in People with Post-Stroke Aphasia

  Acknowledgements This work was conducted as part of a larger NIH-funded project titled “Functional reorganization of the language and domain-general multiple demand systems in aphasia” (NIDCD Grant 1R01DC016950, PIs: Swathi Kiran and Evelina Fedorenko). It reflects a collaborative effort from current and former researchers at the Boston University Center for Brain Recovery, including Maria […]

Faculty Feature: Archana Venkataraman

              Dr. Venkataraman is an Associate Professor at Boston University, a Core Faculty member for the Center for Brain Recovery, and the Principal Investigator for the BU Neural Systems Analysis Laboratory.   Q&A with Archana Venkataraman What is your current research focus, and how does it align with the […]

Daniel Marcelo’s Stroke Story

  In honor of National Stroke Awareness Month, we would like to highlight the story of Daniel Marcelo, a stroke survivor who started language therapy with the BU Center for Brain Recovery in 2022 as part of a randomized, controlled clinical trial entitled “Predicting Rehabilitation Outcomes using Computational Modeling (PROCoM)”.  If you would like to […]

CBR Seminar Series: Sigfus Kristinsson

Behavioral speech-language therapy (SLT) is the most effective and widely used approach for treating post-stroke aphasia. While effective on average, individual variability in treated recovery continues to be problematic for the development of personalized treatment protocols. Recent research shows that many individuals show a selective response to one treatment paradigm over another, highlighting the need to consider individual and treatment-specific factors—and their interaction—as guides in personalized treatment planning. However, prognostic factors for treatment success remain elusive and understudied.